February 21, 2012 -- Dualsystems Biotech has selected Bulldog Bio to represent their complete line of protein discovery products to researchers in the US. This grows the scope of their previous relationship to now include marketing and support of Dualsystems’ proprietary group of protein screening services. This line provides pharmaceutical, biotechnology and academic labs access to Dualsystems’ patented proteomics technology. The two companies hope to double the size of the service products within two years.
Ella Fontaine, V.P. of Communications for Bulldog Bio, offers her perspective “Based upon their patented yeast two hybrid technology, Dualsystems screening services can provide qualified and relevant interactors in a fraction of the time of conventional screens, and with near guaranteed success. Over the past ten years Dualsystems has performed thousands of screens on hundreds of proteins. Their highly optimized process promises researchers a world class experience.”
“We are happy to expand our collaboration with such a highly engaged distributor as Bulldog Bio to include our yeast two hybrid service panel along with our products on the US market” Andreas J. Schulze, CEO of Dualsystems said.
Dualsystems Biotech is a privately held biotechnology company established in 2000 as a spin-off from the University Zurich, Switzerland. Dualsystems has positioned itself as a leading provider of screening services to the international research community in the pharmaceutical, biotech, agrochemical and cosmetic industries as well as academia. For more information about Dualsystems Biotech please visit www.dualsystems.com.
Bulldog Bio Incorporated is a privately held company headquartered in Portsmouth, NH, that distributes tools to Life Science researchers. Please visit www.bulldog-bio.com for more information about the company and its products.
